1,204 results on '"Frankel, David S."'
Search Results
252. Diagnostic Specificity of Basal Inferoseptal Triangular Late Gadolinium Enhancement for Identification of Cardiac Sarcoidosis
253. Ventricular Tachycardia Ablation Remains Treatment of Last Resort in Structural Heart Disease: Argument for Earlier Intervention
254. Catheter ablation of atrial arrhythmias following lung transplant: Electrophysiological findings and outcomes
255. Association of septal late gadolinium enhancement on cardiac magnetic resonance with ventricular tachycardia ablation targets in nonischemic cardiomyopathy
256. Strategies for Catheter Ablation of Left Ventricular Papillary Muscle Arrhythmias
257. Ablation of Ventricular Arrhythmias From the Left Ventricular Apex in Patients Without Ischemic Heart Disease
258. Improvement in tricuspid regurgitation following catheter ablation of atrial fibrillation
259. Association of scar distribution with epicardial electrograms and surface ventricular tachycardia QRS duration in nonischemic cardiomyopathy
260. Risk Stratification of Patients With Apparently Idiopathic Premature Ventricular Contractions
261. Evaluation of Radiofrequency Ablation Irrigation Type
262. Collateral injury of the conduction system during catheter ablation of septal substrate in nonischemic cardiomyopathy
263. Premature atrial complex–induced cardiomyopathy: Case report and literature review
264. Wire countertraction for sheath placement through stenotic and tortuous veins: The “body flossing” technique
265. IMPACT OF CONTACT FORCE SENSING TECHNOLOGY ON ACUTE PROCEDURAL OUTCOMES AND CHRONIC PULMONARY VEIN RECONNECTION RATES IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING CATHETER ABLATION
266. INCIDENCE AND DETERMINANTS OF INAPPROPRIATE SHOCK IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS WITH SUBCUTANEOUS IMPLANTABLE DEFIBRILLATORS
267. Trends in Successful Ablation Sites and Outcomes of Ablation for Idiopathic Outflow Tract Ventricular Arrhythmias
268. Non–Scar-Related and Purkinje-Related Ventricular Tachycardia in Patients With Structural Heart Disease
269. Foreword
270. Reply: Pill-in-the-Pocket Therapy for Atrial Fibrillation: Is There More to Say?
271. Risk Stratification of Patients With Apparently Idiopathic Premature Ventricular Contractions A Multicenter International CMR Registry
272. Incidence and Predictors of Pacing-Induced Right Ventricular Cardiomyopathy
273. Interatrial septal tachycardias following atrial fibrillation ablation or cardiac surgery: Electrophysiological features and ablation outcomes.
274. 84 - Ischemic Heart Disease
275. Impact of a nurse‐led limited risk factor modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation
276. Incidence of Left Atrial Appendage Triggers in Patients With Atrial Fibrillation Undergoing Catheter Ablation
277. Characterization of Structural Changes in Arrhythmogenic Right Ventricular Cardiomyopathy With Recurrent Ventricular Tachycardia After Ablation
278. Septal Versus Lateral Mitral Isthmus Ablation for Treatment of Mitral Annular Flutter
279. Clinical and electrophysiological characteristics of idiopathic ventricular arrhythmias originating from the slow pathway region
280. Comparison of the arrhythmogenic substrate between men and women with nonischemic cardiomyopathy
281. Catheter ablation of premature ventricular complexes with low intraprocedural burden guided exclusively by pace‐mapping
282. Improvement in ventricular function with rhythm control of atrial arrhythmias may delay the need for atrioventricular valve surgery in adults with congenital heart disease
283. Abstract 562: Comprehensive Arteriovenous Metabolomics in the Human Heart
284. The Heart Rhythm Society/American College of Physicians Atrial Fibrillation Screening and Education Initiative
285. Ischemic ventricular tachycardia from below the posteromedial papillary muscle, a particular entity: Substrate characterization and challenges for catheter ablation
286. Use of a novel bipolar sealer device in pocket infections: A case series
287. Performance of Prognostic Heart Failure Models in Patients With Nonischemic Cardiomyopathy Undergoing Ventricular Tachycardia Ablation
288. Comparison of the Ventricular Tachycardia Circuit Between Patients With Ischemic and Nonischemic Cardiomyopathies
289. Electrocardiographic and Electrophysiologic Characteristics of Idiopathic Ventricular Arrhythmias Originating From the Basal Inferoseptal Left Ventricle
290. Septal Coronary Venous Mapping to Guide Substrate Characterization and Ablation of Intramural Septal Ventricular Arrhythmia
291. Long term follow‐up after ventricular tachycardia ablation in patients with congenital heart disease
292. Feasibility of complex transfemoral electrophysiology procedures in patients with inferior vena cava filters
293. Safety and outcomes of catheter ablation for atrial fibrillation in adults with congenital heart disease: A multicenter registry study
294. Noninvasive Programmed Ventricular Stimulation-Guided Management Following Ventricular Tachycardia Ablation
295. Papillary muscle ventricular arrhythmias in patients with arrhythmic mitral valve prolapse: Electrophysiologic substrate and catheter ablation outcomes
296. P‐wave morphology and multipolar intracardiac atrial activation to facilitate nonpulmonary vein trigger localization
297. “As Needed” nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study
298. 2021 HRS Educational Framework for Clinical Cardiac Electrophysiology
299. Utility of Prolonged Duration Endocardial Ablation for Ventricular Arrhythmias Originating From the Left Ventricular Summit
300. Defibrillation testing of the subcutaneous implantable cardioverter-defibrillator at the time of generator replacement.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.